共 16 条
Critical Imbalance of TNF-α and Soluble TNF Receptor 1 in a Patient with Macrophage Activation Syndrome: Potential Implications for Diagnostics and Treatment
被引:23
作者:
Flammiger, Anna
[1
]
Fiedler, Walter
[1
]
Bacher, Ulrike
[2
]
Bokemeyer, Carsten
[1
]
Schneider, Marion
[3
]
Binder, Mascha
[1
]
机构:
[1] Univ Med Ctr Hamburg Eppendorf, Hubertus Wald Canc Ctr, Dept Hematol & Oncol, DE-20246 Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Hubertus Wald Canc Ctr, Dept Stem Cell Transplantat, DE-20246 Hamburg, Germany
[3] Univ Med Ctr Ulm, Dept Anesthesiol, Sect Expt Anesthesiol, Ulm, Germany
关键词:
Macrophage activation syndrome;
Hemophagocytic syndrome;
TNF-alpha;
Soluble TNF receptor 1;
Etanercept;
TUMOR-NECROSIS-FACTOR;
PLASMA-LEVELS;
INFLAMMATION;
DISEASE;
INJURY;
D O I:
10.1159/000338179
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Macrophage activation syndrome (MAS) is a life-threatening disease with sustained activation of inflammatory cells and release of proinflannmatory TNF-alpha. Under physiological conditions, TNF-a initiates a negative feedback mechanism, mediated by shedded, soluble TNF receptor ectodomains, eventually limiting the inflammatory reaction. Here, we report on a 27-year-old critically ill patient with refractory MAS and an insufficient negative feedback regulation, resulting in an overwhelming inflammatory response. A personalized treatment with soluble TNF receptor etanercept resulted in a durable remission. Further studies are warranted to establish whether the TNF cytokine profile may help to successfully guide patient selection for biological therapies. Copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码:69 / 72
页数:4
相关论文